Navigation Links
Jazz Pharmaceuticals And Gentium S.p.A. Announce Agreement For Jazz Pharmaceuticals To Acquire Gentium For $57.00 Per Share
Date:12/19/2013

eived benefits of the proposed acquisition as rapidly or to the extent anticipated by financial analysts or investors, the market price of Jazz Pharmaceuticals' ordinary shares could decline; and those other risks detailed under the caption "Risk Factors" and elsewhere in Jazz Pharmaceuticals'  and Gentium's U.S. Securities and Exchange Commission ("SEC") filings and reports, including in Jazz Pharmaceuticals' Quarterly Report on Form 10-Q for the quarter ended September 30, 2013 and Gentium's Annual Report on Form 20-F for the year ended December 31, 2012, each of which is filed with the SEC, and future filings and reports by either company. Neither Jazz Pharmaceuticals nor Gentium undertakes any duty or obligation to update any forward-looking statements contained in this press release as a result of new information, future events or changes in its expectations.

Additional Information and Where to Find It
The tender offer for the outstanding shares of Gentium (including those shares represented by American Depositary Shares) referenced in this press release has not yet commenced.  This announcement is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell shares of Gentium, nor is it a substitute for the tender offer materials that Jazz Pharmaceuticals and its acquisition subsidiary will file with the SEC upon commencement of the tender offer.  At the time the tender offer is commenced, Jazz Pharmaceuticals and its acquisition subsidiary will file tender offer materials on Schedule TO, and Gentium will file a Solicitation/Recommendation Statement on Schedule 14D-9 with the SEC with respect to the tender offer. The tender offer materials (including an Offer to Purchase, a related Letter of Transmittal and certain other tender offer documents) and the Solicitation/Recommendation Statement will contain important information.  Holders of shares of Gentium are urged to read these documen
'/>"/>

SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Educational Grant Awarded to Winner of Ferring Pharmaceuticals Inaugural Heart to Heart Video Contest
2. Prolong Pharmaceuticals Adds Industry Veteran Ronald Jubin To Executive Management Team
3. Avista Capital Partners Announces a Majority Investment in Vertical Pharmaceuticals and Trigen Laboratories
4. Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
5. Everett Laboratories Acquires Quinnova Pharmaceuticals to Diversify U.S. Pharmaceutical Presence
6. Smithers Quality Assessments Expands Certification Services to Include Pharmaceuticals Industry
7. Partnerships, Appointments, New Products, Public Offerings, and Agreements - Research Report on Questcor Pharmaceuticals, Hologic, IDEXX, Endologix, and Healthways
8. AcelRx Pharmaceuticals Presents ARX-04 Dose-Finding Phase 2 Study Data at Anesthesia Medical Conference
9. Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 2b Frozen Shoulder Syndrome Study of Collagenase Clostridium Histolyticum
10. Rafarma Pharmaceuticals Announces a $1.2 Million Private Placement
11. AcelRx Pharmaceuticals Adds New Board Member
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 6, 2015  The fairness of the proposed acquisition ... Alexion Pharmaceuticals, Inc. ("Alexion") is being investigated by WeissLaw ... for possible breaches of fiduciary duty and other violations ... for agreeing to sell the Company to Alexion.  On ... for Alexion to acquire GEVA in a transaction valued ...
(Date:5/6/2015)... -- Cardica, Inc. (Nasdaq: CRDC ) today announced financial ... 2015. Cardica,s management will hold a conference call at ... and provide an update on the company,s business. ... fiscal 2015, we reintroduced a modified MicroCutter XCHANGE® 30 ... controlled commercial release is focusing primarily on customers in ...
(Date:5/6/2015)... Corp. (NASDAQ and MTA: CTIC) today reported financial results ... "After reporting positive top-line results from ... the quarter, we have subsequently received positive feedback from ... the potential opportunity for pacritinib to meet a current ... myelofibrosis, specifically in the portion of patients that have ...
Breaking Medicine Technology:WeissLaw LLP Investigates the Synageva Biopharma Corp. Acquisition 2Cardica Announces Fiscal 2015 Third Quarter Financial Results 2Cardica Announces Fiscal 2015 Third Quarter Financial Results 3Cardica Announces Fiscal 2015 Third Quarter Financial Results 4Cardica Announces Fiscal 2015 Third Quarter Financial Results 5Cardica Announces Fiscal 2015 Third Quarter Financial Results 6CTI BioPharma Reports First Quarter 2015 Financial Results 2CTI BioPharma Reports First Quarter 2015 Financial Results 3CTI BioPharma Reports First Quarter 2015 Financial Results 4CTI BioPharma Reports First Quarter 2015 Financial Results 5CTI BioPharma Reports First Quarter 2015 Financial Results 6CTI BioPharma Reports First Quarter 2015 Financial Results 7CTI BioPharma Reports First Quarter 2015 Financial Results 8CTI BioPharma Reports First Quarter 2015 Financial Results 9
... Calif., Dec. 20, 2010 Leader Ventures, an investment ... equipment financing to Carmot Therapeutics Inc., an innovative drug ... drug-discovery platform invented by Carmot co-founders Stig K. Hansen ... used to identify promising drug candidates in a broad ...
... Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) ... of a rolling submission for a Biologics License Application ... for the use of metreleptin to treat diabetes and/or ... patients with rare forms of lipodystrophy. Consistent with the ...
Cached Medicine Technology:Leader Ventures Supports Innovative Drug Discovery Company Carmot 2Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy 2Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy 3Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy 4
(Date:5/6/2015)... (PRWEB) May 06, 2015 The Beryl ... 1 of Patient Experience Journal (PXJ), an international, ... practices around understanding and improving patient experience. The second ... patient experience conversation globally, helps align the voices engaged ... , Published in association with The Beryl Institute, ...
(Date:5/6/2015)... “ SideChef ” was featured on NewsWatch as ... latest and coolest applications on the market for iOS, Android, and ... the app review and shared with viewers how this application walks ... to be a good navigator people had to know how to ... is a master navigator. Well what if people could “GPS” their ...
(Date:5/6/2015)... Inversion Studios, a full-service training ... Pilates classes, provides personalized individual instruction and now ... its new Pilates Ring magic circle. , Inversion ... stronger, more centered and graceful, Inversion Studios and ... to healthy fitness through yoga and Pilates. With ...
(Date:5/6/2015)... 06, 2015 Vancouver Chiropractic Clinic, ... their new blog containing the Canadian Physical Activity ... Canadian Society for Exercise Physiology (CSEP). Since the ... health and fitness research and personal training in ... are highly beneficial and a rich resource for ...
(Date:5/6/2015)... Anitoa Systems, (“Anitoa”), a Palo Alto startup established ... successfully demonstrated a handheld real time quantitative-polymerase-chain-reaction system (qPCR) ... qPCR is shown to be capable of detecting several ... C, and E. Coli. This qPCR system has achieved ... 9 orders of magnitude dynamic range. A key ...
Breaking Medicine News(10 mins):Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 3Health News:Vancouver Chiropractor Shares Canadian Physical Activity and Sedentary Behavior Guidelines by CSEP in New Blog 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 3
... all been there: sitting,in the doctor,s waiting room for ... when a long wait is coupled with a hurried ... , "When doctors keep their ... combination of factors can be toxic," says patient satisfaction,expert ...
... Dictation technology within the NHS produces significant efficiency gains. , ... ... today announced that Sheffield Teaching Hospitals NHS Foundation Trust has implemented ... 5 hospitals on 2 campuses in one of the largest rollouts ...
... in an asthmatic,s exhaled breath can portend worsening ... attack linked to underlying airway inflammation. This has ... children, of significant interest as a potential way ... outcomes. However, a recent multi-center prospective study found ...
... has ignored their cost saving suggestionsHARRISBURG, Pa., Jan. 6 ... on closing the state,s budget shortfall, SEIU Local 668, ... across Pennsylvania, said they have identified millions of dollars ... should cancel contracts with private contractors for work that ...
... National Cholesterol Education Program tools, NCEP, do not accurately ... at the Yale University School of Medicine in New ... who had no history of coronary heart disease; although ... Lipitor) because of increased risk of developing coronary heart ...
... 6 Gen-Probe Incorporated (Nasdaq: GPRO ) announced ... J.P. Morgan Healthcare Conference on Wednesday, January 14, 2009 at ... is scheduled to be webcast live and may be accessed ... at www.gen-probe.com . The webcast will be available for ...
Cached Medicine News:Health News:DrScore.com Identifies 'Toxic Combination' 2Health News:Sheffield Teaching Hospitals NHS Foundation Trust delivers same day patient discharge via BigHand Digital Dictation 2Health News:Sheffield Teaching Hospitals NHS Foundation Trust delivers same day patient discharge via BigHand Digital Dictation 3Health News:NO help: Nitric oxide monitoring does not help most children with asthma 2Health News:NO help: Nitric oxide monitoring does not help most children with asthma 3Health News:State Human Services Union Identifies Ways to Save Millions of Tax Dollars 2Health News:Gen-Probe to Webcast Presentation at the 27th Annual J.P. Morgan Healthcare Conference 2
... Integre Duo is the first ... and green wavelengths. This advanced,laser ... instantly,select either a red or ... maximizes,treatment options and ensures effective,patient ...
... Gathering, managing, and transmitting data ... you were hired for. Dawnings ResultNet/Plus ... running your lab, not your communications ... with transmitting result data from largescale ...
... a comprehensive hemodynamic monitoring and information ... Patient demographics, clinical hemodynamic data, ... information all flow seamlessly into one ... data entry. Both images ...
Exxcel Soft ePTFE vascular graft, designed for exceptional kink resistance and crush resistance, maintains a Soft touch for easier handling during peripheral vascular bypass procedures and vascular a...
Medicine Products: